STTR Phase I: Leveraging Sequencing to Identify and Predict Multidrug Resistance — NSF Award to INFORMUTA, INC. (LA, $275,000)
The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to develop a platform for detecting genetic antibiotic resistance motifs that are predictive of current and future susceptibility to therapeutics. Antibiotic resistance is a global health crisis that is predicte
| Award title | STTR Phase I: Leveraging Sequencing to Identify and Predict Multidrug Resistance |
|---|---|
| Award ID | 2421262 |
| Awardee | INFORMUTA, INC. |
| City | NEW ORLEANS |
| State | LA |
| Amount obligated | $275,000 |
| Principal investigator | Kalen Hall |
| Program | STTR Phase I |
| Start date | 09/15/2024 |
| Abstract | The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to develop a platform for detecting genetic antibiotic resistance motifs that are predictive of current and future susceptibility to therapeutics. Antibiotic resistance is a global health crisis that is predicted to overtake cancer and heart disease as the leading cause of death by 2050, taking 10 million lives annually. Antibiotic-resistant infections directly cause 1.2 million deaths an |
| Source | NSF Awards |
$799/mo
Try NSFGrants →